AstraZeneca injects further £100m in Cambridge research centre March 7, 2022 AstraZeneca injects another £100m over budget to complete its Cambridge-based research and development centre. The Discovery Centre, or the ‘Disc’ as it is also known, was formally unveiled in November by Prince Charles and business secretary Kwasi Kwarteng. According to The Times, the site has cost the vaccine-maker £1.1bn, which is more than three times [...]
Astra Zeneca revenues jump over 40 per cent amid vaccine rollout February 10, 2022 Revenues at Astra Zeneca have risen 41 per cent, with Covid-19 vaccine sales boosting its performance across the year.
Pfizer accused of funding anti-AstraZeneca information December 5, 2021 US drugmaker Pfizer, the world’s dominant Covid vaccine maker, has been accused of funding educational presentations that said its UK rival AstraZeneca was ineffective and even dangerous for some members of the population. A Channel 4 Dispatches investigation due to be broadcast this week says it has “uncovered evidence” that Pfizer funded a number of [...]
UK scientists discover what causes blood clot complications in AstraZeneca Covid vaccine December 2, 2021 UK scientists believe they have found the reason behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca vaccine. According to an international team of researchers from Cardiff and the US, the reaction can be traced to the way the adenovirus used by the vaccine to shuttle the coronavirus’ genetic material into cells binds [...]
‘Don’t freak out’: Vaccine bosses attempt to diffuse Omicron-induced jab fears November 30, 2021 Vaccine leaders have rushed to put out the fires of Moderna CEO’s jab cautions, urging the world: “Don’t freak out”. Pharmaceutical heavyweights have been gathering data on the latest Covid-19 variant Omicron, as concerns swell that a tailor-made vaccine may be necessary. AstraZeneca is already researching locations where the variant has been identified, namely in [...]
AstraZeneca opens new £1bn research fortress in Cambridge for army of 2,200 scientists November 25, 2021 AstraZeneca has officially opened The Discovery Centre (DISC) in Cambridge, its newest research and development facility which will swing open its doors to 2,200 research scientists from today. The new £1bn facility will include robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and [...]
Covid-19 global pandemic to be ‘regional epidemic’ by next year, says AstraZeneca boss November 23, 2021 AstraZeneca boss Pascal Soriot said that he expects the global Covid-19 pandemic to become a regional epidemic by next year, after the pharmaceutical giant decided to start profiting from its vaccine. The chief executive of the pharmaceutical giant told Sky News that by 2022, “essentially most of the world at that point will be in [...]
AstraZeneca sales jump 50 per cent as vaccine crawls to profitability November 12, 2021 AstraZeneca’s revenues have soared 32 per cent this year to $25.4bn, powered by booming product sales. Third quarter revenues are up 50 per cent, with the pharmaceutical giant enjoying a $9.87 billion increase in revenues over the three-month period. The company has sold 2.2 billion vaccines since the start of the year. It has now [...]
AstraZeneca says new Coronavirus antibody treatment can prevent as well as cure Covid-19 October 11, 2021 AstraZeneca said in a filing this morning that a new antibody treatment the British pharma giant has developed has the ability to prevent as well as treat Covid-19. The company has filed a request to the US Food and Drug Administration (FDA) last week for emergency use authorisation for AZD7442, which is made up of [...]
Oxford-AstraZeneca vaccine creator to make keynote speech at UK’s Global Investment Summit October 11, 2021 The UK’s pharmaceutical industry is set to take top billing at the UK’s Global Investment Summit next week, with GlaxoSmithKline’s chief executive and one of the creator’s of the Oxford-AstraZeneca vaccine to deliver keynote speeches. GSK chief Dame Emma Walmsley and Oxford University vaccinologist Sarah Gilbert will be alongside World Trade Organisation (WTO) director-general Dr [...]